🇺🇸 FDA
Pipeline program

dipyridamole

02-202-1

Approved small_molecule terminated

Quick answer

dipyridamole for Coronary Artery Disease is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Coronary Artery Disease
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials